About this Event
This event is presented as part of Melbourne Connect's A.I. at Melbourne Colloquium Series in association with the Technopreneurship Program (made possible with support from Airwallex).
Artificial intelligence (AI) algorithms are increasingly being implemented in breast cancer screening to detect cancers in mammographic images. This presentation explores the use of an AI-based cancer detection algorithm not only to identify current cancers but also to predict intermediate-term breast cancer risk (up to four years), supporting the development of more personalised, risk-based screening strategies to further reduce breast cancer deaths through early detection.
About the Speaker
Associate Professor Helen Frazer, MBBS, FRANZCR, M EPI, GAICD.
Associate Professor Helen Frazer is a radiologist and AI researcher with over 20 years’ experience in breast cancer screening. She is currently Clinical Director at St Vincent’s BreastScreen, Associate Professor at University of Melbourne, Member of the RANZCR AI committee and Chief Investigator for Australia’s only AI program building algorithms for breast cancer detection and risk prediction (BRAIx). Helen has authored publications on AI datasets, AI development and testing for screening, AI integration pathways, AI breast cancer risk prediction and the ethical, legal and social implications of AI in healthcare. She is leading the first randomised controlled trial of AI for high consequence medical decision-making in Australia, with the deployment of the BRAIx algorithm in BreastScreen Victoria and BreastScreen South Australia. Helen was a visiting scholar at Stanford University’s Center for AI in Medicine and Imaging in 2022, was recognised as the ANZ “Women in AI” 2022 Innovator of the Year, and was recently awarded the 2025 MECCA Prize for Healthcare Innovation.
Event Venue & Nearby Stays
Melbourne Connect - The Studio (Ground Level), 700 Swanston Street, Carlton, Australia
AUD 0.00
